TPM3 and neoplasm: The recognition of this fusion in various neoplasms highlights the importance of molecular diagnostics in identifying actionable targets for therapy, particularly with the advent of TRK inhibitors that have shown efficacy in treating tumors with NTRK gene fusions [19].